Glucose monitor maker Know Labs expands leadership team

[Image from Know Labs]Non-invasive glucose monitor developer Know Labs (OTCQB:KNWN) announced today that it added two executives to its leadership team.

Seattle-based Know Labs — which aims to make the first non-invasive glucose monitor cleared by the FDA — added Steven Kent as its new chief product officer, along with Peter Conley as its CFO and SVP of intellectual property.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

Know Labs signs research agreement with Mayo Clinic

Know Labs today said it entered a research agreement with the Mayo Clinic to test and validate its Bio-RFID as a continuous glucose monitor.

Know Labs’ Bio-RFID technology is designed to be integrated in a number of wearable, mobile or bench-top form factors.

“We are very pleased to work with Mayo Clinic. They bring a world-renowned reputation in diagnostics. We look forward to working with them during this research project as we continue the development of our non-invasive UBand CGM,” Know Labs CEO Phil Bosua said in a news release.

Know Labs plans to launch its Bio-RFID within its wearable UBand as a non-invasive continuous glucose monitor.

Read more
  • 0